Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Aug 7, 2026, 5:22 PM EST
Rapid Dose Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is March - February.
Millions CAD. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Net Income | -3.17 | -3.39 | -5.4 | -4.31 | -3.81 | -8.49 |
Depreciation & Amortization | 0.5 | 0.51 | 0.24 | 0.62 | 0.63 | 0.77 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 4.08 |
Stock-Based Compensation | 0.23 | 0.37 | 1.57 | 0.16 | 0.71 | 1.7 |
Provision & Write-off of Bad Debts | - | - | - | -0.01 | 0.02 | - |
Other Operating Activities | 1.07 | 1.07 | 0.93 | 0.75 | 0.13 | 0.15 |
Change in Accounts Receivable | 0.08 | 0.13 | -0.08 | -0.07 | 0.02 | 0.2 |
Change in Inventory | 0.1 | 0.09 | -0.11 | 0.01 | 0.08 | -0.04 |
Change in Accounts Payable | 1.42 | 0.94 | 1.64 | 0.62 | 1.31 | -0.47 |
Change in Unearned Revenue | - | - | - | -0.01 | -0.01 | -0.88 |
Change in Other Net Operating Assets | -0.03 | 0 | 0.07 | -0.06 | 0.06 | -0.02 |
Operating Cash Flow | 0.21 | -0.27 | -1.15 | -2.29 | -0.86 | -3 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | - | -0 | -0.01 | - | - | -0.04 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0 |
Cash Acquisitions | - | - | - | - | - | 1.89 |
Investing Cash Flow | - | -0 | -0.01 | - | - | 1.85 |
Short-Term Debt Issued | - | 0.19 | - | 0.43 | 0.81 | 0.13 |
Long-Term Debt Issued | - | 0.46 | - | 1.83 | 0.2 | - |
Total Debt Issued | 0.55 | 0.65 | - | 2.26 | 1.01 | 0.13 |
Short-Term Debt Repaid | - | -0.24 | -0.35 | -0.7 | - | - |
Long-Term Debt Repaid | - | -0.15 | -0.03 | -0.34 | -0.31 | -0.29 |
Total Debt Repaid | -0.44 | -0.39 | -0.38 | -1.04 | -0.31 | -0.29 |
Net Debt Issued (Repaid) | 0.11 | 0.26 | -0.38 | 1.22 | 0.7 | -0.16 |
Issuance of Common Stock | - | - | 1.39 | 1.3 | 0.15 | 1.28 |
Other Financing Activities | -0.38 | - | - | -0.09 | - | - |
Financing Cash Flow | -0.27 | 0.26 | 1.01 | 2.43 | 0.86 | 1.13 |
Foreign Exchange Rate Adjustments | - | - | - | - | 0 | -0.02 |
Net Cash Flow | -0.06 | -0.01 | -0.14 | 0.13 | -0.01 | -0.04 |
Free Cash Flow | 0.21 | -0.27 | -1.15 | -2.29 | -0.86 | -3.04 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 8.18% | -9.78% | -55.27% | -224.91% | -120.27% | -173.52% |
Free Cash Flow Per Share | 0.00 | -0.00 | -0.01 | -0.02 | -0.01 | -0.03 |
Levered Free Cash Flow | -0.2 | -0.04 | -0.06 | -1.89 | 0.55 | -1.55 |
Unlevered Free Cash Flow | 0.59 | 0.72 | 0.71 | -1.48 | 0.72 | -1.47 |
Cash Interest Paid | - | - | - | - | 0.08 | 0.07 |
Change in Working Capital | 1.58 | 1.16 | 1.52 | 0.49 | 1.46 | -1.21 |